Loading...
XJPX4977
Market cap82mUSD
Jan 20, Last price  
721.00JPY
1D
1.69%
1Q
-18.53%
Jan 2017
-2.57%
IPO
49.90%
Name

Nitta Gelatin Inc

Chart & Performance

D1W1MN
XJPX:4977 chart
P/E
—
P/S
0.32
EPS
—
Div Yield, %
2.40%
Shrs. gr., 5y
-0.24%
Rev. gr., 5y
2.08%
Revenues
40.42b
+3.15%
27,923,134,00027,763,016,00028,772,135,00032,814,056,00031,914,983,00036,885,000,00036,575,000,00037,777,000,00036,464,000,00034,543,000,00030,550,000,00031,783,000,00039,186,000,00040,420,000,000
Net income
-1.85b
L
1,051,672,0001,375,869,0001,565,879,000665,490,000610,067,000477,000,000693,000,000-615,000,000989,000,000-694,000,000742,000,000726,000,0001,558,000,000-1,850,000,000
CFO
4.91b
P
1,570,410,000568,211,0002,050,213,000-692,883,0002,074,146,0002,385,000,0001,910,000,0001,419,000,0002,232,000,0001,969,000,0003,509,000,0001,044,000,000-540,000,0004,911,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Nitta Gelatin Inc. engages in the production and sale of edible gelatin, pharmaceutical gelatin, and photographic gelatin in Japan. The company manufactures and sells related products made from collagen for animal bones and skin, and fish scales and skin; and gelatin for applications in industrial sectors comprising food and pharmaceutical markets; collagen peptide, which is recognized as a bioactive compound and a material that has bioregulatory functions, produced using its proteolytic technology. It also manufactures other food materials; and stabilizers for confectionery, desserts, delicatessen items, chilled foods, etc. In addition, the company manufactures and sells collagen and medical gelatin for medical device manufacturers, research institutions, and others that are used as a biomaterial for artificial skin and bone. Nitta Gelatin Inc. was founded in 1918 and is headquartered in Osaka, Japan.
URL
https://www.nitta-gelatin.co.jp/
IPO date
Dec 20, 2011
Employees
1,023
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
40,420,000
3.15%
39,186,000
23.29%
31,783,000
4.04%
Cost of revenue
38,583,000
37,208,000
30,468,000
Unusual Expense (Income)
NOPBT
1,837,000
1,978,000
1,315,000
NOPBT Margin
4.54%
5.05%
4.14%
Operating Taxes
1,112,000
542,000
630,000
Tax Rate
60.53%
27.40%
47.91%
NOPAT
725,000
1,436,000
685,000
Net income
(1,850,000)
-218.74%
1,558,000
114.60%
726,000
-2.16%
Dividends
(308,000)
(253,000)
(235,000)
Dividend yield
2.37%
1.62%
1.95%
Proceeds from repurchase of equity
(3,000)
BB yield
0.02%
Debt
Debt current
5,368,000
6,235,000
4,371,000
Long-term debt
5,010,000
5,242,000
4,522,000
Deferred revenue
5,000
1,586,000
1,560,000
Other long-term liabilities
1,432,000
19,000
23,000
Net debt
3,165,000
4,541,000
1,007,000
Cash flow
Cash from operating activities
4,911,000
(540,000)
1,044,000
CAPEX
(2,170,000)
(2,159,000)
(1,329,000)
Cash from investing activities
(3,022,000)
(1,498,000)
(1,325,000)
Cash from financing activities
(1,610,000)
1,824,000
(762,000)
FCF
3,155,000
(3,242,000)
(1,844,000)
Balance
Cash
4,080,000
2,856,000
3,046,000
Long term investments
3,133,000
4,080,000
4,840,000
Excess cash
5,192,000
4,976,700
6,296,850
Stockholders' equity
19,443,000
36,885,000
33,884,000
Invested Capital
28,303,000
29,434,300
23,997,150
ROIC
2.51%
5.38%
2.99%
ROCE
5.36%
5.67%
4.26%
EV
Common stock shares outstanding
18,150
18,122
18,096
Price
717.00
-16.92%
863.00
29.58%
666.00
-0.75%
Market cap
13,013,749
-16.79%
15,639,582
29.77%
12,051,801
-0.81%
EV
20,259,749
40,772,582
31,649,801
EBITDA
3,562,000
3,608,000
2,733,000
EV/EBITDA
5.69
11.30
11.58
Interest
190,000
171,000
97,000
Interest/NOPBT
10.34%
8.65%
7.38%